Request Your Free White Paper Now:

"Integrated Market Access Strategies Are Needed Now More Than Ever"

Building a Sustainable Blueprint for a Holistic Market Access Strategy

Innovation in the pharma/life sciences arena has brought a shift toward targeted, often high-cost therapies aimed at smaller patient populations. These therapies require a comprehensive, unified market access strategy to ensure access for patients and to optimize brand success.

In this latest article, Ellen Cappellino, SVP, Market Access & Patient Services for EVERSANA, discusses how to integrate people, technology, real-world data and infrastructure to develop market access strategies that address:

• Administrative barriers that impede patient access
• Financial barriers that create challenges in affordability
• Clinical barriers that hinder patient adherence

Offered Free by: EVERSANA
See All Resources from: EVERSANA